NO961779D0 - Multilamelær liposomal arachidonsyre metabolit formuleringer - Google Patents
Multilamelær liposomal arachidonsyre metabolit formuleringerInfo
- Publication number
- NO961779D0 NO961779D0 NO961779A NO961779A NO961779D0 NO 961779 D0 NO961779 D0 NO 961779D0 NO 961779 A NO961779 A NO 961779A NO 961779 A NO961779 A NO 961779A NO 961779 D0 NO961779 D0 NO 961779D0
- Authority
- NO
- Norway
- Prior art keywords
- arachidonic acid
- acid metabolite
- prostaglandins
- formulations
- multilamellar liposomal
- Prior art date
Links
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical class CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 208000035475 disorder Diseases 0.000 abstract 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 abstract 2
- 150000003180 prostaglandins Chemical class 0.000 abstract 2
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 abstract 1
- 206010004053 Bacterial toxaemia Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 208000013222 Toxemia Diseases 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 229960000711 alprostadil Drugs 0.000 abstract 1
- 230000001668 ameliorated effect Effects 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000002502 liposome Substances 0.000 abstract 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Saccharide Compounds (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14789893A | 1993-11-04 | 1993-11-04 | |
| US15285293A | 1993-11-16 | 1993-11-16 | |
| US18008994A | 1994-01-11 | 1994-01-11 | |
| PCT/US1994/012710 WO1995012389A1 (en) | 1993-11-04 | 1994-11-03 | Multilamellar liposomal arachidonic acid metabolite formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO961779D0 true NO961779D0 (no) | 1996-05-02 |
| NO961779L NO961779L (no) | 1996-05-02 |
| NO312810B1 NO312810B1 (no) | 2002-07-08 |
Family
ID=27386612
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19961778A NO312809B1 (no) | 1993-11-04 | 1996-05-02 | Fremgangsmåter for fremstilling av en farmasöytisk sammensetning ved anvendelse av unilamell¶re liposomalearachidonsyremetabolitt formuleringer samt anvendelse derav |
| NO19961779A NO312810B1 (no) | 1993-11-04 | 1996-05-02 | Multilamell¶r liposomal arachidonsyre metabolitt formuleringer og en fremgangsmåte for fremstilling av etmedikament derav |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19961778A NO312809B1 (no) | 1993-11-04 | 1996-05-02 | Fremgangsmåter for fremstilling av en farmasöytisk sammensetning ved anvendelse av unilamell¶re liposomalearachidonsyremetabolitt formuleringer samt anvendelse derav |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP0726763B1 (no) |
| JP (2) | JPH09511216A (no) |
| KR (2) | KR100355246B1 (no) |
| AT (2) | ATE184785T1 (no) |
| AU (2) | AU8130894A (no) |
| CA (2) | CA2175057A1 (no) |
| DE (2) | DE69423773T2 (no) |
| DK (2) | DK0726763T3 (no) |
| ES (2) | ES2136271T3 (no) |
| GR (2) | GR3032006T3 (no) |
| NO (2) | NO312809B1 (no) |
| PT (1) | PT726763E (no) |
| WO (2) | WO1995012388A1 (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10507737A (ja) * | 1994-01-11 | 1998-07-28 | ザ リポソーム カンパニー、インコーポレーテッド | アラキドン酸代謝産物および粒子製剤を用いる治療 |
| US6747027B1 (en) | 1996-07-22 | 2004-06-08 | Pharmacia Corporation | Thiol sulfonamide metalloprotease inhibitors |
| PL331369A1 (en) * | 1996-07-22 | 1999-07-05 | Monsanto Co | Thiosulphonic metaloprotease inhibitors |
| WO1998039316A1 (en) | 1997-03-04 | 1998-09-11 | Monsanto Company | N-hydroxy 4-sulfonyl butanamide compounds |
| WO1998039326A1 (en) | 1997-03-04 | 1998-09-11 | Monsanto Company | Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| US6638952B1 (en) | 1997-03-04 | 2003-10-28 | Pharmacia Corporation | Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| US20010039287A1 (en) | 1997-11-14 | 2001-11-08 | Thomas E Barta | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| RU2250105C2 (ru) | 1997-11-14 | 2005-04-20 | Дж.Д.Сёрл ЛЛС | Ароматическая сульфонгидроксамовая кислота в качестве ингибитора металлопротеаз |
| US6750228B1 (en) | 1997-11-14 | 2004-06-15 | Pharmacia Corporation | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| EP1157021A1 (en) | 1999-02-08 | 2001-11-28 | G.D. SEARLE & CO. | Sulfamato hydroxamic acid metalloprotease inhibitor |
| US6583299B1 (en) | 1999-05-20 | 2003-06-24 | G.D. Searle & Co. | α-amino-β-sulfonyl hydroxamic acid compounds |
| US6683078B2 (en) | 2001-07-19 | 2004-01-27 | Pharmacia Corporation | Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| JP2003342196A (ja) * | 2002-05-31 | 2003-12-03 | Mukku:Kk | 静脈注射用組成物、その製造法およびその製剤 |
| WO2013039851A1 (en) | 2011-09-12 | 2013-03-21 | Mallinckrodt Llc | Optical agents for imaging and visualization of matrix metalloproteinase enzymes |
| CN111053743B (zh) * | 2018-10-16 | 2023-07-14 | 石药集团中奇制药技术（石家庄）有限公司 | 一种前列地尔脂质体及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5262168A (en) * | 1987-05-22 | 1993-11-16 | The Liposome Company, Inc. | Prostaglandin-lipid formulations |
| KR970005171B1 (ko) * | 1987-05-22 | 1997-04-14 | 더 리포조옴 캄파니, 인코포레이티드 | 아라키돈산 대사물질 관련 리포좀 제조방법 및 그 제제 |
| JPH0395118A (ja) * | 1989-09-07 | 1991-04-19 | Green Cross Corp:The | プロスタグランジン含有脂肪小体製剤 |
| JPH04356421A (ja) * | 1991-03-06 | 1992-12-10 | Green Cross Corp:The | プロスタグランジン類含有脂肪小体組成物 |
| ATE176401T1 (de) * | 1991-05-07 | 1999-02-15 | Liposome Co Inc | Liposomale prostaglandinformulierungen |
| JPH05139977A (ja) * | 1991-05-17 | 1993-06-08 | Green Cross Corp:The | プロスタグランジン類リポソーム複合体を充填した注射器 |
-
1994
- 1994-11-03 AU AU81308/94A patent/AU8130894A/en not_active Abandoned
- 1994-11-03 DE DE69423773T patent/DE69423773T2/de not_active Expired - Fee Related
- 1994-11-03 DE DE69420859T patent/DE69420859T2/de not_active Expired - Fee Related
- 1994-11-03 CA CA002175057A patent/CA2175057A1/en not_active Abandoned
- 1994-11-03 WO PCT/US1994/012579 patent/WO1995012388A1/en not_active Ceased
- 1994-11-03 AT AT95900532T patent/ATE184785T1/de not_active IP Right Cessation
- 1994-11-03 ES ES95900532T patent/ES2136271T3/es not_active Expired - Lifetime
- 1994-11-03 JP JP7513378A patent/JPH09511216A/ja active Pending
- 1994-11-03 DK DK95900504T patent/DK0726763T3/da active
- 1994-11-03 KR KR1019960702299A patent/KR100355246B1/ko not_active Expired - Fee Related
- 1994-11-03 DK DK95900532T patent/DK0726764T3/da active
- 1994-11-03 AU AU81326/94A patent/AU687921B2/en not_active Ceased
- 1994-11-03 WO PCT/US1994/012710 patent/WO1995012389A1/en not_active Ceased
- 1994-11-03 JP JP7513436A patent/JPH09504793A/ja not_active Abandoned
- 1994-11-03 EP EP95900504A patent/EP0726763B1/en not_active Expired - Lifetime
- 1994-11-03 CA CA002175896A patent/CA2175896A1/en not_active Abandoned
- 1994-11-03 KR KR1019960702298A patent/KR100355247B1/ko not_active Expired - Fee Related
- 1994-11-03 EP EP95900532A patent/EP0726764B1/en not_active Expired - Lifetime
- 1994-11-03 ES ES95900504T patent/ES2144118T3/es not_active Expired - Lifetime
- 1994-11-03 AT AT95900504T patent/ATE191141T1/de not_active IP Right Cessation
- 1994-11-03 PT PT95900504T patent/PT726763E/pt unknown
-
1996
- 1996-05-02 NO NO19961778A patent/NO312809B1/no not_active IP Right Cessation
- 1996-05-02 NO NO19961779A patent/NO312810B1/no not_active IP Right Cessation
-
1999
- 1999-11-30 GR GR990403099T patent/GR3032006T3/el unknown
-
2000
- 2000-06-29 GR GR20000401517T patent/GR3033817T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0726764T3 (da) | Multilamel-liposomale arachidonsyremetabolitformuleringer | |
| MX9302244A (es) | Composicion de gel acuoso de retinoides. | |
| WO2002094210A3 (de) | Kosmetische mittel | |
| MX9307686A (es) | Preparacion de liberacion sostenida. | |
| ES2148593T3 (es) | Compuestos retinoides trienoicos novedosos y metodos. | |
| BR9811094A (pt) | Agente terapêutico para tumores linfáticos | |
| ES2180164T3 (es) | Agentes acuosos para el cuidado de la piel y del cabello. | |
| AR021946A1 (es) | Composiciones que contienen feniramina y metodo para el tratamiento de las respuestas alergicas | |
| ES2179295T3 (es) | Composiciones que contienen un antifungico y un compuesto de azufre. | |
| ES2174293T3 (es) | Microesferas farmaceuticas de acido valproico para la administracion oral. | |
| BR9912223A (pt) | Agente terapêutico para crise hipercalcêmica | |
| ES2141978T3 (es) | Retinoides triciclicos, metodos para su produccion y uso. | |
| DK0729352T3 (da) | Interdigiteringsfusionsliposomer indeholdende arachidonsyremetabolitter | |
| AR019893A1 (es) | Un metodo para reducir o evitar el mal olor | |
| PA8436301A1 (es) | Compuestos de amonio cuaternario | |
| KR950700685A (ko) | 최음제로서 사용되는 요드화수소산(use of hydriodic acid as an aphrodisiac) | |
| NO20032035D0 (no) | Terapeutiske midler for heratokonjunktivitis sykdommer omfattende farnesyleddiksyre som aktiv ingrediens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |